@mikead63 One possible future treatment I have been following. I think it may be in clinical trials now. Yes, the Fibroblast Growth Factor 1 (FGF1) protein shows strong promise in preclinical models for treating neuropathy and neuropathic pain. However, it remains highly experimental and is not yet an approved treatment for human patients. [1, 2, 3, 4]
Here is how FGF1 shows potential and where the research stands:
How FGF1 Targets Neuropathy

• Nerve Regeneration: FGF1 stimulates the proliferation and migration of Schwann cells (the cells that insulate and support nerves), which helps repair damaged myelin and regenerate nerve fibers.
• Pain Reduction: Preclinical studies indicate that FGF1 can reverse mechanical and thermal hypersensitivity—key symptoms of neuropathic pain—by reducing neuroinflammation in the spinal cord.
• Diabetic Neuropathy: In diabetic models, FGF1 has been shown to counteract oxidative stress and inflammation, actively protecting nerves from high blood-sugar damage. [3, 11]

Current Limitations and Risks

• Human Data is Limited: The most promising results for FGF1 come from animal studies. Clinical trials in humans are scarce, and it is not yet an FDA-approved therapy for neuropathy.
• Delivery and Side Effects: Growth factors like FGF1 are difficult to deliver safely across the nervous system, and there are theoretical risks that stimulating cell growth could lead to abnormal cell division or tumor formation. [1, 4]

Currently, standard neuropathy treatments primarily focus on symptom management and blood-sugar control rather than direct nerve regeneration. [12, 13, 14, 15, 16]
If you are managing a specific type of neuropathy (such as diabetic peripheral neuropathy), tell me:What are your primary symptoms (e.g., pain, numbness, tingling)?Are you currently taking any medications for pain relief?I can provide more tailored information regarding available options.
AI responses may include mistakes.

[1] https://www.youtube.com/watch
[2] https://pmc.ncbi.nlm.nih.gov/articles/PMC8019860/
[3] https://pmc.ncbi.nlm.nih.gov/articles/PMC7819983/
[4] https://pmc.ncbi.nlm.nih.gov/articles/PMC12985528/
[5] https://blueridgeintegrativehealth.com/blog/enhancing-neuropathy-treatment-with-nitric-oxide-our-comprehensive-approach
[6] https://medresearch.umich.edu/research-news/stephanie-eid-phd-earns-important-grant
[7] https://pubmed.ncbi.nlm.nih.gov/25589163/
[8] https://pubmed.ncbi.nlm.nih.gov/28949091/
[9] https://www.sciencedirect.com/science/article/abs/pii/S0006899325001738
[10] https://pmc.ncbi.nlm.nih.gov/articles/PMC5974208/
[11] https://pmc.ncbi.nlm.nih.gov/articles/PMC12010074/
[12] https://www.nhs.uk/conditions/peripheral-neuropathy/treatment/
[13] https://www.cdc.gov/diabetes/diabetes-complications/diabetes-and-nerve-damage.html
[14] https://www.mayoclinic.org/diseases-conditions/diabetic-neuropathy/diagnosis-treatment/drc-20371587
[15] https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2019.00929/full
[16] https://arpwave.com/understanding-neuropathy-and-how-arpwave-can-help/